Plasma Study
This clinical trial focuses on plasma research to study diseases such as Rheumatoid Arthritis, Lupus, Sjogren’s Syndrome, and Scleroderma. The goal is to enhance understanding of these autoimmune conditions and develop improved diagnostic and treatment strategies.
ELIGIBILITY CRITERIA
We are seeking participants who meet the following criteria:
- Diagnosed with one of the following autoimmune diseases:
- Rheumatoid Arthritis
- Lupus
- Sjogren’s Syndrome
- Scleroderma
Study Details
Participants in this clinical trial will undergo plasma sampling and analysis to investigate biomarkers and disease mechanisms associated with the specified autoimmune conditions. The study will involve regular assessments conducted by a team of medical professionals to monitor disease progression and response to potential interventions.
During the trial, participants will attend scheduled visits for plasma collection and health evaluations. The study aims to identify specific plasma components that correlate with disease activity, which may lead to the development of targeted therapies and personalized treatment plans.
Interventions:
Plasma sampling and analysis to study biomarkers and disease mechanisms in autoimmune conditions.
Do you meet the criteria and want to join the study?
If you meet the criteria and are interested in contributing to this important research, you may qualify for this study. For more information or to discuss your eligibility, please contact the Haltha team at Haltha Connect.
Take part in live studyUnlock Exclusive Content by Subscribing to Our Updates
Stay informed about the latest advancements, breakthroughs, and trends in medical research
